The long-term effect of menopause on postmenopausal bone loss in Japanese women: Results from a prospective study

被引:46
|
作者
Okano, H
Mizunuma, H
Soda, M
Kagami, I
Miyamoto, S
Ohsawa, M
Ibuki, Y
Shiraki, M
Suzuki, T
Shibata, H
机构
[1] Gunma Univ, Sch Med, Dept Obstet & Gynecol, Gunma 371, Japan
[2] Res Inst & Practice Involut Dis, Nagano, Japan
[3] Tokyo Metropolitan Inst Gerontol, Dept Epidemiol, Tokyo, Japan
关键词
D O I
10.1359/jbmr.1998.13.2.303
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study ws to elucidate perimenopausal bone loss in relation to menstrual conditions and to investigate the long-term effect of menopause on bone loss in aged women. The rate of change in bone mineral density (BMD) was measured twice at an exact interval of 12 months by dual-energy X-ray absorptiometry (DXA) at the lumbar spine in 176 pre-and postmenopausal healthy women 41-65 years of age. Serum follicle-stimulating hormone, intact and N-fragment osteocalcin (OC), three types of vitamin D-3, parathyroid hormone (PTH), and calcitonin were also determined. Women who exercised regularly or had anatomical changes at the lumbar spine were excluded from this study. The subjects were divided into eight groups based on their menstrual status and years since menopause. Annual bone loss at the lumbar spine of premenopausal women with regular menstruation was -0.2 +/- 1.9% (95% confidence interval, -0.9 similar to-0.4%) and was not statistically different from zero, while that of women with irregular menstruation or at menopausal transition,vas -2.1 +/- 3.4% (-3.4 similar to-0.8%), and -3.3 +/- 2.3% (-5.2 similar to-0.3%), respectively, and was significantly different from zero. Serum OC levels of women at menopausal transition were significantly higher than those of women with regular menstruation, suggesting that bone loss had commenced in these women. The rate of annual change in BMD of women who were menopausal for 1-3, 4-6, 10-12, and more than 13 years was -3.1 +/- 4.0% (-4.7 similar to-1.5%), -1.2 +/- 2.6% (-2.2 similar to-0.2%), -1.0 +/- 3.0% (-2.3 similar to-0.3%), and -2.3 +/- 2.1% (-3.7 similar to-1.0%), respectively, and was significantly less than zero. But the annual bone loss of women who were menopausal for 7-9 years was -1.5 +/- 2.6% (-3.0 similar to-0.1%) and was not statistically significant from zero. These results indicate that postmenopausal women lose BMD in two phases. The early bone loss is rapid and commences during irregular menstruation, then is attenuated within 6 years after the onset of menopause. The second bone loss commences after the attenuation of the first bone loss. Among bone metabolic hormones, intact PTH alone showed an age-related increase and was suggested as being a causal factor of bone loss in women who were menopausal for 13 years or more.
引用
收藏
页码:303 / 309
页数:7
相关论文
共 50 条
  • [21] EFFECT OF LONG-TERM ADMINISTRATION OF PROGESTOGEN ON POSTMENOPAUSAL BONE LOSS - RESULT OF A 2-YEAR, CONTROLLED RANDOMIZED STUDY
    TREMOLLIERES, F
    POUILLES, JM
    RIBOT, C
    CLINICAL ENDOCRINOLOGY, 1993, 38 (06) : 627 - 631
  • [22] Anabolic Effect of Long-term Estrogen Replacement on Bone Collagen in Elderly Postmenopausal Women with Osteoporosis
    G. Khastgir
    J. Studd
    N. Holland
    J. Alaghband-Zadeh
    T. J. Sims
    A. J Bailey
    Osteoporosis International, 2001, 12 : 465 - 470
  • [23] Anabolic effect of long-term estrogen replacement on bone collagen in elderly postmenopausal women with osteoporosis
    Khastgir, G
    Studd, J
    Holland, N
    Alaghband-Zadeh, J
    Sims, TJ
    Bailey, AJ
    OSTEOPOROSIS INTERNATIONAL, 2001, 12 (06) : 465 - 470
  • [24] Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study
    A Zeleniuch-Jacquotte
    R E Shore
    K L Koenig
    A Akhmedkhanov
    Y Afanasyeva
    I Kato
    M Y Kim
    S Rinaldi
    R Kaaks
    P Toniolo
    British Journal of Cancer, 2004, 90 : 153 - 159
  • [25] Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study
    Zeleniuch-Jacquotte, A
    Shore, RE
    Koenig, KL
    Akhmedkhanov, A
    Afanasyeva, Y
    Kato, I
    Kim, MY
    Rinaldi, S
    Kaaks, R
    Toniolo, P
    BRITISH JOURNAL OF CANCER, 2004, 90 (01) : 153 - 159
  • [26] Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis
    Eriksen, EF
    Melsen, F
    Sod, E
    Barton, I
    Chines, A
    BONE, 2002, 31 (05) : 620 - 625
  • [27] PROSPECTIVE AND CROSS-SECTIONAL STUDY OF RADIAL BONE LOSS IN POSTMENOPAUSAL WOMEN
    JOHNSTON, CC
    SMITH, DM
    KHAIRI, MRA
    CALCIFIED TISSUE RESEARCH, 1976, 21 : 365 - 369
  • [28] Factors affecting bone loss around menopause in women without HRT:: a prospective study
    Sirola, J
    Kröger, H
    Honkanen, R
    Jurvelin, JS
    Sandini, L
    Tuppurainen, MT
    Saarikoski, S
    MATURITAS, 2003, 45 (03) : 159 - 167
  • [29] Long-term effects of weight loss on breast cancer biomarkers in postmenopausal women
    McTiernan, A.
    Duggan, C.
    Tapsoba, Jd D.
    Mason, C.
    Wang, C-Y
    CANCER RESEARCH, 2017, 77
  • [30] Long-Term Prospective Study of an Orthodontic Bone Anchor
    Mommaerts, Maurice Y.
    Nols, Valerie
    De Pauw, Guy
    INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS, 2014, 29 (02) : 419 - 426